Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort [NA]

View source ↗

Summary

The study aims to evaluate immune responses after Hepatitis B revaccination in a young cohort and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis B, Vaccination; Infection | NA | Status: RECRUITING